Results 121 to 130 of about 38,393 (221)

Haemoglobin A1c Time‐In‐Range and Mortality in Adults With Diabetes

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Reduced A1c time in range and particularly greater time below range are associated with increased mortality in adults with diabetes. A1c stability within person‐specific ranges may be a risk predictor for major outcomes in adults with diabetes. ABSTRACT Introduction Glycemic variability over time is a risk factor for diabetes complications.
Paul R. Conlin   +8 more
wiley   +1 more source

Pioglitazone and Risk of Chronic Obstructive Pulmonary Disease in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study

open access: yesInternational Journal of COPD, 2022
Chin-Hsiao Tseng1– 3 1Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; 2Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan ...
Tseng CH
doaj  

In Silico Analysis of Phytochemicals of Native Pakistani Plants Having Antidiabetic Potential Targeting GLP‐1R and SGLT2 Proteins

open access: yesFood Science &Nutrition, Volume 14, Issue 4, April 2026.
This study examines the potential of phytochemicals from native Pakistani plants to mitigate the effects of diabetes by interacting with GLP‐1R and SGLT2 proteins using bioinformatics methods, thereby highlighting the application of bioinformatics in this context.
Malaika Ajaz   +9 more
wiley   +1 more source

The Role of Dietary Safflower Oil in the Management of Glucose Levels in Obese Postmenopausal Women with Type 2 Diabetes Mellitus [PDF]

open access: yes, 2011
With more than 8% of people in the United States diagnosed with type 2 diabetes, it is imperative to develop treatments that improve glycemic control (1).
Guo, Karen
core  

Assessing Research Impact With Bibliometrics and Altmetrics: The Case of the Canadian Network for Observational Drug Effect Studies (CNODES)

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 4, April 2026.
ABSTRACT Purpose Our purpose was to measure the research output and impact of the Canadian Network for Observational Drug Effect Studies (CNODES). Methods We used OpenAlex to collect metadata on citation counts for all 115 CNODES articles published between January 2011 and March 2022. We obtained the altmetric scores from Altmetric.com.
Alexandra M. Yip   +5 more
wiley   +1 more source

Real‐world relationship between blood biomarker‐based PhenoAge, metformin, and Alzheimer's disease

open access: yesAlzheimer's &Dementia: Translational Research &Clinical Interventions, Volume 12, Issue 2, April/June 2026.
Abstract INTRODUCTION The biological aging process could be an important Alzheimer's disease (AD) pathogenesis. Metformin might be beneficial in anti‐aging and cognition and has mixed associations with AD and/or dementia. METHODS We used a US nationwide insurance claims dataset. We used Cox models to investigate the relationship between blood biomarker‐
Yi Shi   +6 more
wiley   +1 more source

Pregnane X Receptor Regulates Human Endocrine System by Inducing Sex Hormone–Binding Globulin Expression

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 138, Issue 4, April 2026.
ABSTRACT Sex hormone–binding globulin (SHBG) is a sex hormone carrier. We aimed to characterize the role of pregnane X receptor (PXR), a major regulator of drug metabolism, in SHBG regulation. Serum SHBG was measured in four clinical trials (n = 61) and expression in in vitro experiments in human 3D hepatocyte spheroids and HepG2 cells.
Maria H. Ahonen   +5 more
wiley   +1 more source

Comparison of cardiovascular outcomes between once‐weekly semaglutide and dulaglutide in adults with type 2 diabetes and established atherosclerotic cardiovascular disease in the United States

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 2661-2671, April 2026.
Abstract Aims This study aims to compare the risk of major adverse cardiovascular events (MACE) among United States individuals with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD) treated with once‐weekly semaglutide vs. dulaglutide.
Xi Tan   +7 more
wiley   +1 more source

Thiazolidinediones

open access: yesNew England Journal of Medicine, 2004
Derek Grubb, JR Greenfield, DJ Chisholm
openaire   +3 more sources

A Review of the Anti-diabetic Activity of Andrographis Paniculata (Burm. F.) Nees Based In-vivo Study [PDF]

open access: yes, 2015
Diabetes mellitus (DM) is ricing nowadays. DM is a metabolic deasease characterized by increasing of glucose blood level for prolonged time. Patient with DM must take medicine for lowering glucose levels in whole life.
Harimurti, S. (Sabtanti)   +1 more
core  

Home - About - Disclaimer - Privacy